Overview

A Study of N9 Chemotherapy in Children With Neuroblastoma

Status:
Recruiting
Trial end date:
2022-06-22
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out whether N9 is a safe and effective treatment for children with neuroblastoma. N9 includes 3 different combinations of chemotherapy drugs that are given at different times - Cyclophosphamide, topotecan, and vincristine (CTV), Ifosfamide, carboplatin, and etoposide (ICE), Cyclophosphamide, doxorubicin, and vincristine (CDV).
Phase:
Early Phase 1
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Treatments:
Carboplatin
Cyclophosphamide
Doxorubicin
Etoposide
Ifosfamide
Topotecan
Vincristine